LEXX Q1 2026 Earnings Narrower Loss Surprises as Bioscience Firm Advances Drug Delivery Pipeline Design Therapeutics Inc DSGN Q1 2026 Earnings Narrower Loss Surpasses Expectations Amid Quiet Quarter GRNT Q1 2026 Earnings EPS Misses Estimates by Over 80 Adamas Trust ADAML Q1 2026 Earnings Preferred Stock Delivers Strong EPS Beat on FixedtoFloating Rate Structure SGHC Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Uptick GLDG Q1 2026 Earnings NarrowerThanExpected Loss Reflects Cost Discipline in PreRevenue Stage